KURA · NASDAQ
Kura Oncology (KURA) Stock Price & Fundamentals
Kura Oncology (KURA) closed at $279.64 on Oct 9, 2026, down 1.29% from the previous close of $283.30.
Share price, past year
1Y −8.22%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $279.64 |
| Sep 30, 2026 | $285.88 |
| Aug 31, 2026 | $304.22 |
| Jul 31, 2026 | $293.69 |
| Jun 30, 2026 | $300.20 |
| May 29, 2026 | $309.76 |
| Apr 30, 2026 | $312.20 |
| Mar 31, 2026 | $310.60 |
| Feb 27, 2026 | $304.07 |
| Jan 30, 2026 | $282.10 |
| Dec 31, 2025 | $278.11 |
| Nov 28, 2025 | $286.30 |
| Oct 31, 2025 | $299.88 |
Key statistics
- Market cap
- $24.88B
- P/E (TTM)
- —
- EPS (TTM)
- −$3.37
- Revenue (TTM)
- $77.23M
- Net income (TTM)
- −$296.78M
- Shares outstanding
- 89M
- Dividend yield
- —
- 52-week range
- $278.11 – $323.92
Kura Oncology's market cap is $24.88B, based on a share price of $279.64 and 89M shares outstanding as of Jun 30, 2026.
Financials
Kura Oncology reported revenue of $67.48M for fiscal 2025, up 25.24% from fiscal 2024.
Kura Oncology reported a net loss of $278.67M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $67.48M | +25.2% | −$278.67M | −413.0% | −$3.18 | −$70.70M |
| FY2024ended Dec 31, 2024 | $53.88M | — | −$173.98M | −322.9% | −$2.02 | $133.85M |
| FY2023ended Dec 31, 2023 | $0.00 | — | −$152.63M | — | −$2.08 | −$124.99M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $20.87M | −$68.33M | −$0.77 |
| Q1 FY2026ended Mar 31, 2026 | $18.27M | −$73.33M | −$0.83 |
| Q4 FY2025ended Dec 31, 2025 | $17.34M | −$81.00M | −$0.92 |
| Q3 FY2025ended Sep 30, 2025 | $20.75M | −$74.12M | −$0.85 |
| Q2 FY2025ended Jun 30, 2025 | $15.29M | −$66.12M | −$0.75 |
| Q1 FY2025ended Mar 31, 2025 | $14.11M | −$57.43M | −$0.66 |
Company profile
- Name
- Kura Oncology, Inc.
- Ticker
- KURA
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 4930 Directors Place, Suite 500, San Diego, CA 92121
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001422143
Recent SEC filings
- Sep 9, 2026
- Sep 8, 2026
- Aug 12, 2026
- Aug 12, 2026
- Jul 29, 2026
- Jun 4, 2026
- May 12, 2026
- May 12, 2026
Frequently asked questions
What is Kura Oncology's stock price?
Kura Oncology (KURA) closed at $279.64 on Oct 9, 2026, down 1.29% from the previous close of $283.30.
What is Kura Oncology's market cap?
Kura Oncology's market cap is $24.88B, based on a share price of $279.64 and 89M shares outstanding as of Jun 30, 2026.
How much revenue does Kura Oncology make?
Kura Oncology reported revenue of $67.48M for fiscal 2025, up 25.24% from fiscal 2024.
Does Kura Oncology pay a dividend?
Kura Oncology's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Kura Oncology, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures